PC12 cells were cultured in DMEM containing 10% fetal bovine serum and 5% horse serum, and cultured at 37°C with 95% humidity and 5% CO2 (20 (link)). PC12 cells were divided into control, model, model + vehicle (PBS) and model + CPCGI. In the model + vehicle and model + CPCGI groups, PC12 cells were pre-treated with PBS and CPCGI separately for 1 h before stimulation with 50 µM Aβ25–35 (Sigma-Aldrich; Merck KGaA) for 24 h. PC12 cells in the model group were stimulate with 50 µM Aβ25–35 for 24 h (21 (link)). Cells in the control group were not subjected to any treatment. Subsequently, PC12 cells in each group were subjected to the following experiments.
Investigating Neuroprotective Effects of CPCGI in PC12 Cells
PC12 cells were cultured in DMEM containing 10% fetal bovine serum and 5% horse serum, and cultured at 37°C with 95% humidity and 5% CO2 (20 (link)). PC12 cells were divided into control, model, model + vehicle (PBS) and model + CPCGI. In the model + vehicle and model + CPCGI groups, PC12 cells were pre-treated with PBS and CPCGI separately for 1 h before stimulation with 50 µM Aβ25–35 (Sigma-Aldrich; Merck KGaA) for 24 h. PC12 cells in the model group were stimulate with 50 µM Aβ25–35 for 24 h (21 (link)). Cells in the control group were not subjected to any treatment. Subsequently, PC12 cells in each group were subjected to the following experiments.
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Hebei Medical University, Second Hospital of Hebei Medical University
Variable analysis
- Treatment with CPCGI
- Treatment with PBS (vehicle)
- Cell viability/survival
- Cell culture medium (DMEM with 10% fetal bovine serum and 5% horse serum)
- Cell culture conditions (37°C, 95% humidity, 5% CO2)
- Amyloid-beta (Aβ25-35) concentration (50 µM)
- Control group (no treatment)
- Model group (Aβ25-35 treatment only)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!